Additionally, in multicellular tumor spheroids and in doxorubicin-resistant human breast adenocarcinoma cells, the inhibition of glycolysis raised intracellular ROS, downregulated P-gp and reverted the MDR phenotype8, 23. Here, PGP is linked to breast adenocarcinoma.